Sheila Swaroop Quoted in Allure on Patent Strategy for Beauty and Skincare Products
In a recent interview with Allure, Knobbe Martens Litigation Practice Chair Sheila Swaroop weighed in on the intellectual property aspects of skincare brand SkinCeuticals’ recent reformulation of their C E...
OBBBA’s Construction Deadline Has Passed – Now the Continuity Risk Begins
Key Takeaways: The One Big Beautiful Bill Act (OBBBA) accelerated development timelines across the renewable energy sector by creating a limited window for developers to preserve valuable federal tax incentives....
Brian Horne Named Among Los Angeles Business Journal’s 2026 “Leaders of Influence: Litigators & Trial Attorneys”
LOS ANGELES, July 16, 2026 – Knobbe Martens is pleased to share that litigation partner Brian Horne was recognized in the 2026 edition of Los Angeles Business Journal’s “Leaders of...
Profiles in Leadership Journal Recognizes Four Knobbe Martens Partners in 2026 Mid-Year Leadership Awards
IRVINE, Calif., July 14, 2026 – Leading intellectual property law firm Knobbe Martens is pleased to share that four of the firm’s partners—Jessica Achtsam, Charlene Azema, Irfan Lateef, and Christy...
When “About” Becomes Indefinite: Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v. Safe Foods
Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance, “about” may...
Space Tech Investment Grows in 2026 Amid Congressional Proposals Affecting Contractual IP Rights
Key Takeaways: Private investment in space technology continues an upward trend in 2026, with increasing growth in late stage and venture growth deals, including private equity purchases. Against a backdrop...
Changes to Mexican Patent Law May Impact Life Science Patent Prosecution
Key Takeaway: While recent amendments to Mexico’s patent laws promote faster prosecution and earlier decisions on patents, concerns abound as to the feasibility and integrity of the prosecution process. On...
Sheila Swaroop Named Among “Most Influential Women in IP” by World Intellectual Property Review
IRVINE, Calif., July 9, 2026 – Knobbe Martens is pleased to announce that partner Sheila Swaroop was recognized in the 2026 edition of World Intellectual Property Review (WIPR)’s “Most Influential...
Knobbe Martens Secures Victory for SharkNinja with Dismissal of Patent Infringement Lawsuit
IRVINE, Calif., July 9, 2026 – A team from leading intellectual property law firm Knobbe Martens delivered a significant win for consumer products company, SharkNinja (NYSE: SN), with the successful...
Trademark & Brand Protection Update | June 2026
AI Training and Fair Use Ari Feinstein, Jonathan Menkes & Cassidy McCleary While the legal landscape is continuing to take shape, a number of recent court decisions indicate that unlicensed use...
Jeremiah Helm and Sean Murray Analyze Federal Circuit Ruling on “About” and Patent Claim Indefiniteness in Law360
In their latest Law360 column on recent notable Federal Circuit decisions, Knobbe Martens partners Jeremiah Helm and Sean Murray analyze the Federal Circuit’s decision in Enviro Tech Chemical Services, Inc....
Aerospace Update | June 2026
Applied Aerospace & Defense’s IPO Signals Continued Momentum in Defense Manufacturing Jacob S. Etling Ongoing geopolitical tensions are leading to an increase in defense-tech contractors filing for IPOs. Aerospace &...
Litigation Update | June 2026
Access Plus Similarity Starts the Clock for Trade Secret Misappropriation Claims Inzer C. Ni & Jordan A. DeOrio A trade secret misappropriation claim accrues when the plaintiff knew or should have...
One Definition and the Walls Come Down – District Court Dismisses Copyright Claim Based on Misclassified Cabinet Registration
Key Takeaway: A federal district court dismissed a copyright infringement claim on the grounds that the work in the asserted registration had been improperly classified under the Copyright Act. This...
What the USPTO’s New 30-Day Director Review Deadline for Decisions Instituting Trial Means for PTAB Petitioners and Patent Owners
Key Takeaway: In a precedential decision in Light & Wonder, Inc. v. Evolution Malta Ltd., U.S. Patent and Trademark Office Director Squires extended the deadline for requesting Director Review of...
Sound Marks – They Are More Than Just “Alright, Alright, Alright”
Key Takeaway: Non-traditional trademarks like sound marks can provide valuable protection for distinctive sounds that function as source identifiers, particularly where other forms of intellectual property protection may be unavailable....
Amendments to Mexico’s Federal Law for Protection of Industrial Property Inform More Flexible International IP Strategy for Biotech Companies
Key Takeaway: Amendments to Mexico’s Federal Law for Protection of Industrial Property align more with U.S. Patent and Trademark Office standards for restoring priority and application revival, increasing international patent...
Knobbe Martens, Partner Brian Horne Honored as Finalists for Tech Industry Litigation Department and IP Attorney of the Year at California Legal Awards
Firm honored for delivering more than $1 billion in jury verdicts and multiple landmark IP litigation wins IRVINE, Calif., June 25, 2026 – Leading intellectual property law firm Knobbe Martens...
Public Funding for Energy Innovation Impacts Private Intellectual Property Rights
Key Takeaway: The value of intellectual property developed using government funds depends upon compliance with disclosure and licensing rules. Public investment is critical to the development and commercialization of energy...
PTAB Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
FDA to Drop 510(k) Requirements for Certain Low-Risk Devices, Lowering Barriers to Entry
On June 5, 2026, the U.S. Food and Drug Administration (FDA) issued updated guidance stating its intent to exempt certain unclassified medical devices from premarket 510(k) requirements, and that the FDA believes the identified device...
